Abiraterone Tosylate is a derivative of Abiraterone (A108490), a steroidal cytochrome P 450 17alpha-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. Molecular Formula: C31H37NO3S Solubility: DCM, Methanol Molecular Weight: 503.7 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
503.7
Form:
Supplied as a Off-White Solid
* VAT and and shipping costs not included. Errors and price changes excepted
